Aymeric Chapuis-Ravel

Ottawa, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

A bitter melon natural compound ameliorates the myotonic dystrophy type 1 skeletal muscle phenotype in a sex-specific manner.

A bitter melon natural compound ameliorates the myotonic dystrophy type 1 skeletal muscle phenotype in a sex-specific manner.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: May 08, 2026

Exercise mimetics as unexplored therapeutics for treating depression.

Exercise mimetics as unexplored therapeutics for treating depression.

Journal: Molecular psychiatry

Published: September 28, 2025

Disruptions of cell signaling pathways in myotonic dystrophy type 1 skeletal muscle, their pathogenic impact, and potential for combinatorial therapeutics.

Disruptions of cell signaling pathways in myotonic dystrophy type 1 skeletal muscle, their pathogenic impact, and potential for combinatorial therapeutics.

Journal: The Journal of biological chemistry

Published: August 02, 2025

Changes in Physiopathological Markers in Myotonic Dystrophy Type 1 Skeletal Muscle: A 3-Year Follow-up Study.

Changes in Physiopathological Markers in Myotonic Dystrophy Type 1 Skeletal Muscle: A 3-Year Follow-up Study.

Journal: Journal of neuromuscular diseases

Published: July 20, 2024

Probing the extent of importin-α targeting of the TAF8 NLS by eliminating its cationic net-charge.

Probing the extent of importin-α targeting of the TAF8 NLS by eliminating its cationic net-charge.

Journal: Protein science : a publication of the Protein Society

Published: July 15, 2024

Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model.

Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model.

Journal: International journal of molecular sciences

Published: December 15, 2022

Combinatorial treatment with exercise and AICAR potentiates the rescue of myotonic dystrophy type 1 mouse muscles in a sex-specific manner.

Combinatorial treatment with exercise and AICAR potentiates the rescue of myotonic dystrophy type 1 mouse muscles in a sex-specific manner.

Journal: Human molecular genetics

Published: June 09, 2022

Sex-dependent role of Pannexin 1 in regulating skeletal muscle and satellite cell function.

Sex-dependent role of Pannexin 1 in regulating skeletal muscle and satellite cell function.

Journal: Journal of cellular physiology

Published: March 13, 2022

Pharmacological and exercise-induced activation of AMPK as emerging therapies for myotonic dystrophy type 1 patients.

Pharmacological and exercise-induced activation of AMPK as emerging therapies for myotonic dystrophy type 1 patients.

Journal: The Journal of physiology

Published: February 07, 2022

Pharmacological inhibition of HDAC6 improves muscle phenotypes in dystrophin-deficient mice by downregulating TGF-β via Smad3 acetylation.

Pharmacological inhibition of HDAC6 improves muscle phenotypes in dystrophin-deficient mice by downregulating TGF-β via Smad3 acetylation.

Journal: Nature communications

Published: January 28, 2022

Combinatorial therapies for rescuing myotonic dystrophy type 1 skeletal muscle defects.

Combinatorial therapies for rescuing myotonic dystrophy type 1 skeletal muscle defects.

Journal: Trends in molecular medicine

Published: January 26, 2022

A novel CARM1-HuR axis involved in muscle differentiation and plasticity misregulated in spinal muscular atrophy.

A novel CARM1-HuR axis involved in muscle differentiation and plasticity misregulated in spinal muscular atrophy.

Journal: Human molecular genetics

Published: August 05, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026